EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
651,953
Share change
-484,871
Total reported value
$6,506,088
Price per share
$9.98
Number of holders
6
Value change
-$4,859,778
Number of buys
3
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q4 2022

As of 31 Dec 2022, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 651,953 shares. The largest 6 holders included Verition Fund Management LLC, Sio Capital Management, LLC, CLEAR STREET LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS Group AG, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 6 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.